IMAGION BIOSYSTEMS LIMITEDIMAGION BIOSYSTEMS LIMITEDIMAGION BIOSYSTEMS LIMITED

IMAGION BIOSYSTEMS LIMITED

No trades
See on Supercharts

IBX fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Imagion Biosystems Ltd. engages in the research and development of non-radioactive and safe diagnostic imaging technology. It offers MagSense technology which does not use ionizing radiation, radioactive tracers, or strong magnetic fields; and PrecisionMRX nanoparticles, which is used for magnetic relaxometry and other biomedical applications where the magnet susceptibility of the nanoparticle can be instrumental. The company was founded by Edward R. Flynn on December 6, 2016 and is headquartered in Melbourne, Australia.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

IBX does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company